Received Jul 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y015108 | — |
No additional AE; HCP reported that VARIVAX and PROQUAD were administered to multiple patients on multiple dates after being improperly stored. This case pertains to one patient who received improperly stored VARIVAX on 06/25/2025; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, previous drugs reactions or allergies and concomitant therapies were not reported. On 25-JUN-2025, the patient was vaccinated with an improperly Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), Injection (lot #Y015108, expiration date: 06-SEP-2026) at a dose of 0.5 mL (route of administration not reported) reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported) for prophylaxis following a temperature excursion of 6.3F for 0 hours 16 minutes 0 seconds. No additional adverse event reported.
Sterile diluent